glofitamab,Obinutuzumab 
roche
['glofitamab', 'lymphoma', 'roche']
roche s glofitamab induced "complete remissions" in 39% of patients w/ diffuse large b-cell lymphoma according to new data from mid-stage study presented by melbourne, australia-based of h/t #asco22 newsletter. 1/n
Founder of Cambridge BioPartners, Inc. I'm also @PearlF on Clubhouse.